Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma ; volume:18 ; number:1 ; day:27 ; month:2 ; year:2018 ; pages:1-12 ; date:12.2018
BMC cancer ; 18, Heft 1 (27.2.2018), 1-12, 12.2018
- Urheber
-
Ma, Ming-Chun
- Beteiligte Personen und Organisationen
-
Chen, Yi-Ju
Chiu, Tai-Jan
Lan, Jui
Liu, Chien-Ting
Chen, Yi-Ching
Tien, Hsin-Ho
Chen, Yen-Yang
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4146-7
- URN
-
urn:nbn:de:1111-201804241278
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ma, Ming-Chun
- Chen, Yi-Ju
- Chiu, Tai-Jan
- Lan, Jui
- Liu, Chien-Ting
- Chen, Yi-Ching
- Tien, Hsin-Ho
- Chen, Yen-Yang
- SpringerLink (Online service)
Ähnliche Objekte (12)
A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
Pathological complete response after chemotherapy in initially unresectable distal cholangiocarcinoma
Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer
Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
Preoperative predictors for early recurrence of resectable pancreatic cancer
Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma
Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma
Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making
A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
Pathological complete response after chemotherapy in initially unresectable distal cholangiocarcinoma
Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer
Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
Preoperative predictors for early recurrence of resectable pancreatic cancer
Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma
Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma
Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making
A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
Pathological complete response after chemotherapy in initially unresectable distal cholangiocarcinoma
Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer
Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
Preoperative predictors for early recurrence of resectable pancreatic cancer
Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma
Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma